Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
72.18
+2.10 (3.00%)
At close: Oct 23, 2026
SHA:688198 Revenue
Beijing Balance Medical Technology had revenue of 110.30M CNY in the quarter ending June 30, 2026, a decrease of -25.42%. This brings the company's total for the last twelve months to 625.98M, up 11.94% year-over-year. In the year 2025, Beijing Balance Medical Technology had annual revenue of 620.15M with 23.57% growth. That makes Beijing Balance Medical Technology the 23,138th largest company in the world by revenue and 4,197th in China.
Revenue (ttm)
625.98M
Revenue Growth
+11.94%
P/S Ratio
15.86
Revenue / Employee
744.32K
Employees
841
Market Cap
9.93B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:688198 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 620.15M | 118.27M | 23.57% |
| Dec 31, 2024 | 501.88M | 131.24M | 35.41% |
| Dec 31, 2023 | 370.64M | 75.47M | 25.57% |
| Dec 31, 2022 | 295.17M | 43.35M | 17.21% |
| Dec 31, 2021 | 251.82M | 69.90M | 38.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sinocare | 4.93B |
| Cofoe Medical Technology | 3.96B |
| Shandong Weigao Blood Purification Products | 3.76B |
| Qingdao Haier Biomedical Co.,Ltd | 2.43B |
| SonoScape Medical | 2.40B |
| Jafron Biomedical | 1.91B |
| Shandong Weigao Orthopaedic Device | 1.49B |
| Shanghai MicroPort Endovascular MedTech | 1.43B |